Skip to main content

Table 3 Site-stratified logistic regression models of the odds of advanced stage and competing risk regression models of the hazard of cancer death among Aboriginal compared with non-Aboriginal people, NSW Cancer Registry 2000–2008

From: After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales

Cancer site Distant stage Distant/regional stage Hazard of cancer death
  AOR (95% CI)a AOR (95% CI)a SHR (95% CI)b
Stomach 1.01 (0.61–1.67) 0.93 (0.57–1.51) 1.23 (0.90–1.67)
Colorectalc 1.28 (0.97–1.69) 1.34 (1.05–1.70) 1.57 (1.32–1.87)
 Colon 0.98 (0.68–1.42) 1.10 (0.81–1.50) 1.44 (1.13–1.84)
 Rectum 1.93 (1.27–2.94) 1.82 (1.21–2.73) 1.78 (1.38–2.30)
Liver 0.66 (0.28–1.59) 0.69 (0.34–1.40) 1.27 (0.91–1.77)
Pancreas 0.83 (0.50–1.38) 0.78 (0.47–1.30) 1.16 (0.91–1.48)
Lung 0.94 (0.76–1.16) 0.95 (0.77–1.17) 1.39 (1.24–1.56)
Melanoma 1.51 (0.71–3.21) 1.61 (0.94–2.74) 1.11 (0.63–1.96)
Breastd 1.62 (1.11–2.36) 1.37 (1.10–1.71) 1.62 (1.22–2.16)
Cervixd 2.05 (0.96–4.37) 1.61 (0.94–2.74) 1.27 (0.80–2.03)
Uterusd 2.19 (1.04–4.64) 1.47 (0.80–2.70) 1.16 (0.67–2.02)
Prostated 2.59 (1.65–4.08) 1.31 (0.90–1.90) 1.86 (1.24–2.77)
Kidney 1.87 (1.16–3.03) 1.55 (1.02–2.38) 0.89 (0.59–1.35)
Bladder 0.85 (0.26–2.79) 1.40 (0.74–2.66) 0.96 (0.57–1.62)
Ill-defined & unspecified & other rare 0.99 (0.64–1.53) 0.83 (0.51–1.34) 1.26 (0.99–1.61)
Otherse 1.63 (1.30–2.04) 1.52 (1.28–1.80) 1.40 (1.23–1.59)
  1. AOR adjusted odds ratio, CI confidence interval, SHR sub-hazard ratio, ICD-O-3 International Classification of Diseases Oncology, SEIFA socio-economic index for areas (Index of relative socio-economic disadvantage).
  2. aAll logistic regression models adjusted for age, sex, year of diagnosis, remoteness and SEIFA. ORs presented for Aboriginal peoples compared with non-Aboriginal people. Separate models for distant and distant/regional as an outcome.
  3. bAll competing risk regression models adjusted for age, sex, year of diagnosis, remoteness, SEIFA and stage. SHRs presented for Aboriginal peoples compared with non-Aboriginal people. Death certificate only cases and cases found at post-mortem were excluded from survival analysis (1.5%) and, therefore, numbers included in stage and survival analyses differ slightly.
  4. cColorectal cancers grouped together and separately for colon (ICD-O-3 C18) and rectum cancers (ICD-O-3 C19-C21).
  5. dOnly females/ males included as relevant. Only female breast cancers included in the models.
  6. eAll other cancer sites categorised to this group.